Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis
- 491 Downloads
Triple-negative breast cancer (TNBC) disproportionately affects black women. However, black race as a prognostic factor in TNBC has not been well studied. We evaluated the effect of race, among other variables, on outcomes in women with TNBC. A total of 704 patients with stages I–III TNBC treated with breast-conserving surgery ± adjuvant radiation therapy (RT) and chemotherapy were identified from an institutional database. Competing risk analyses, Kaplan–Meier methods, and Cox proportional hazards models identified associations among clinicopathologic variables on locoregional recurrence (LRR), distant recurrence (DR), and overall survival (OS). LRR was defined as a biopsy proven, triple receptor-negative recurrence in the ipsilateral breast or regional lymph nodes. At a median follow-up of 51 months, there were 55 LRR, 61 DR, and 111 death events. Compared to non-black women, black women had higher disease stage and were more likely to receive axillary lymph node dissection, chemotherapy, and nodal irradiation (all P < 0.05). After adjustment for stage, age, lymphovascular invasion, chemotherapy, and RT on multivariate analysis, black race was prognostic for increased risk of LRR (hazard ratio [HR] = 3.17; 95 % confidence interval: 1.7–5.8; P = 0.0002). The 5-year risk of regional recurrence was higher in black women (10 vs. 2 %, P < 0.0001), but local failures were similar between groups (3.0 vs. 5.3 %, P = 0.15). RT was an independent predictor for decreased LRR and increased OS on multivariate analyses (P = 0.0006 and P = 0.0003, respectively). Black women with TNBC had equivalent local control, but higher risk of regional nodal failure, compared with non-black counterparts. The routine use of comprehensive nodal irradiation may be beneficial for black women with TNBC.
KeywordsTriple-negative breast cancer Race Recurrence Outcomes
Axillary lymph node dissection
Body mass index
Breast cancer susceptibility genes
Death due to cause other than breast cancer
Memorial Sloan-Kettering Cancer Center
Sentinel lymph node dissection
Triple-negative breast cancer
We thank the staff of the breast disease management team and the clinical genetics service database at MSKCC for their continuous support in maintaining the retrospective database used for this research.
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Morris GJ, Naidu S, Topham AK et al (2007) Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and End Results database. Cancer 110:876–884PubMedCrossRefGoogle Scholar
- 4.Duffy SW, Bowen RL, Ryan DA, et al (2008) Reply: early onset of breast cancer in black British women—how reliable are the findings? Br J Cancer. doi: 10.1038/sj.bjc.6604626
- 8.Greene FL, American Joint Committee on Cancer, American Cancer Society (2002) AJCC cancer staging manual, 6th edn. Springer, New YorkGoogle Scholar
- 16.Christiansen N, Chen L, Gilmore J et al (2012) Association between African American race and outcomes in patients with nonmetastatic triple-negative breast cancer: a retrospective analysis by using results from the Georgia Cancer Specialist Database. Clin Breast Cancer 12:270–275PubMedCrossRefGoogle Scholar
- 20.Nicolaou NFB, Hanlon A (1999) The impact of regional lymphatic irradiation and of the extent of axillary lymph node dissection on regional control in patients with early-stage, node-positive breast cancer, treated with breast-conserving therapy. Proc Am Soc Clin Oncol 18:266Google Scholar
- 27.Whelan TJ, Olivotto I, Ackerman I, Chapman JW, Chua B, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Craighead P, Nolan MC, Bowen J, McCready DR, Pritchard KI, Levine MN, Parulekar W (2011) NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. 2011 ASCO Annual Meeting. J Clin Oncol 29Google Scholar